Addex Therapeutics Ltd. (ADXN) Executive Compensation
Addex Therapeutics Ltd. (ADXN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ADXN
CIK: 1574232
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: V8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO AG
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerPhilipp Kegele
Audit LocationZurich, Switzerland
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-08 | 2026-10-08 | FORM 6-K | 0001171843-26-006524 | View SEC Doc Filr Page |
| 6-K | 2026-10-02 | 2026-10-02 | FORM 6-K | 0001171843-26-006345 | View SEC Doc Filr Page |
| 6-K | 2026-09-28 | 2026-06-30 | 6-K | 0001104659-26-111142 | View SEC Doc Filr Page |
| 6-K | 2026-09-25 | 2026-09-25 | FORM 6-K | 0001171843-26-006225 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | OWNERSHIP DOCUMENT | 0001104659-26-105509 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | OWNERSHIP DOCUMENT | 0001104659-26-105506 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | OWNERSHIP DOCUMENT | 0001104659-26-105501 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | OWNERSHIP DOCUMENT | 0001104659-26-105496 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | OWNERSHIP DOCUMENT | 0001104659-26-105491 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | OWNERSHIP DOCUMENT | 0001104659-26-105489 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | OWNERSHIP DOCUMENT | 0001104659-26-105484 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | OWNERSHIP DOCUMENT | 0001104659-26-105481 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-04 | — | SCHEDULE 13D/A Filing | 0001104659-26-105480 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-27 | — | SCHEDULE 13D/A Filing | 0001104659-26-101798 | View SEC Doc Filr Page |
| 6-K | 2026-08-26 | 2026-08-26 | FORM 6-K | 0001171843-26-005744 | View SEC Doc Filr Page |
| 6-K | 2026-07-08 | 2026-07-08 | FORM 6-K | 0001171843-26-004524 | View SEC Doc Filr Page |
| 6-K | 2026-06-30 | 2026-06-30 | FORM 6-K | 0001171843-26-004375 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | FORM 6-K | 0001104659-26-077470 | View SEC Doc Filr Page |
| 6-K | 2026-06-05 | 2026-06-05 | FORM 6-K | 0001171843-26-003926 | View SEC Doc Filr Page |
| 20-F | 2026-05-15 | 2025-12-31 | FORM 20-F | 0001104659-26-062447 | View SEC Doc Filr Page |
| NT 20-F | 2026-04-30 | 2025-12-31 | NT 20-F | 0001104659-26-052854 | View SEC Doc Filr Page |
| 6-K | 2026-04-30 | 2026-04-30 | FORM 6-K | 0001171843-26-002871 | View SEC Doc Filr Page |
| 6-K | 2026-04-29 | 2026-04-29 | FORM 6-K | 0001171843-26-002787 | View SEC Doc Filr Page |
| 6-K | 2026-04-23 | 2026-04-23 | FORM 6-K | 0001171843-26-002661 | View SEC Doc Filr Page |
| 6-K | 2026-04-21 | 2026-04-21 | FORM 6-K | 0001171843-26-002589 | View SEC Doc Filr Page |